To dissect the characteristics of Fgl2-expressing activated CD8+ T cells, mice were challenged with B16 tumors, and Fgl2 was measured on CD8+ T cells isolated from the blood, draining lymph node, spleen, and tumor via flow cytometry (Fig. 1a). This evidence concerns the gene FGL2 and neoplasm.